NeuroPace Inc. (NPCE)
11.92
-0.19 (-1.57%)
At close: Jan 14, 2025, 3:59 PM
11.84
-0.67%
After-hours Jan 14, 2025, 04:00 PM EST
Company Description
NeuroPace, Inc. operates as a medical device company in the United States.
It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source.
The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely.
It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures.
The company was incorporated in 1997 and is headquartered in Mountain View, California.
NeuroPace Inc.
| Country | United States |
| IPO Date | Apr 22, 2021 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 184 |
| CEO | Joel D. Becker |
Contact Details
Address: 455 North Bernardo Avenue Mountain View, California United States | |
| Website | https://www.neuropace.com |
Stock Details
| Ticker Symbol | NPCE |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001528287 |
| CUSIP Number | 641288105 |
| ISIN Number | US6412881053 |
| Employer ID | 22-3550230 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Joel D. Becker | Chief Executive Officer, President & Director |
| Rebecca L. Kuhn | Chief Financial Officer, Vice President of Finance & Administration |
| Amy Treadwell | Vice President of Human Resources |
| Dr. Martha J. Morrell M.D. | Chief Medical Officer |
| Dylan St. John | Chief of Operations & Development |
| Kelley Nicholas | Vice President of Sales |
| Leah Akin | General Counsel & Corporate Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 08, 2025 | 4 | Filing |
| Jan 08, 2025 | 3 | Filing |
| Jan 08, 2025 | 8-K | Current Report |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 12, 2024 | 10-Q | Quarterly Report |
| Nov 12, 2024 | 8-K | Current Report |
| Nov 04, 2024 | SCHEDULE 13G | Filing |
| Oct 28, 2024 | 4 | Filing |
| Oct 24, 2024 | 4 | Filing |